Literature DB >> 7664186

Cell response to a salt-extractable and sonicated Brucella melitensis 16M antigen in human brucellosis.

M C Moreno-Lafont1, A López-Merino, R López-Santiago.   

Abstract

We compared the immunological responses of leukocytes taken from healthy negative controls, laboratory workers immunized with the phenol-insoluble French vaccine against brucellosis, patients acutely ill with brucellosis, and patients chronically infected with Brucella melitensis. A salt-extractable antigen (protein-rich but with traces of lipopolysaccharide) and a sonicated suspension from B. melitensis 16M were used as antigens for in vitro lymphocyte proliferation test. Quantitation of T cells showed that the ratio of CD4+/CD8+ cells decreased as the condition of the patient deteriorated. An assay to quantitate the cell-mediated immunity showed that the activities of mononuclear cells stimulated with concanavalin A increased as the disease progressed as well.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7664186      PMCID: PMC170163          DOI: 10.1128/cdli.2.3.377-380.1995

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  17 in total

1.  The thiobarbituric acid assay of sialic acids.

Authors:  L WARREN
Journal:  J Biol Chem       Date:  1959-08       Impact factor: 5.157

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Comparative protection of mice against virulent and attenuated strains of Brucella abortus by passive transfer of immune T cells or serum.

Authors:  L N Araya; A J Winter
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

4.  Temporal development of protective cell-mediated and humoral immunity in BALB/c mice infected with Brucella abortus.

Authors:  L N Araya; P H Elzer; G E Rowe; F M Enright; A J Winter
Journal:  J Immunol       Date:  1989-11-15       Impact factor: 5.422

5.  Immunogenicity of Brucella abortus salt-extractable proteins.

Authors:  L B Tabatabai; B L Deyoe; J M Patterson
Journal:  Vet Microbiol       Date:  1989-05       Impact factor: 3.293

6.  Effect of recombinant human macrophage colony-stimulating factor 1 on immunopathology of experimental brucellosis in mice.

Authors:  A G Doyle; W J Halliday; C J Barnett; T L Dunn; D A Hume
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

7.  Characterization of salt-extractable protein antigens from Brucella abortus by crossed immunoelectrophoresis and isoelectricfocusing.

Authors:  L B Tabatabai; B L Deyoe
Journal:  Vet Microbiol       Date:  1984-10       Impact factor: 3.293

8.  Endogenous gamma interferon mediates resistance to Brucella abortus infection.

Authors:  Y Zhan; C Cheers
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

9.  Release of outer membrane fragments by exponentially growing Brucella melitensis cells.

Authors:  C Gamazo; I Moriyón
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

10.  Cytokine response of T-cell subsets from Brucella abortus-infected mice to soluble Brucella proteins.

Authors:  Y Zhan; J Yang; C Cheers
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

View more
  3 in total

1.  CD80/CD28 co-stimulation in human brucellosis.

Authors:  P Skendros; P Boura; F Kamaria; M Raptopoulou-Gigi
Journal:  Clin Exp Immunol       Date:  2006-12       Impact factor: 4.330

2.  Brucella abortus inhibits major histocompatibility complex class II expression and antigen processing through interleukin-6 secretion via Toll-like receptor 2.

Authors:  Paula Barrionuevo; Juliana Cassataro; M Victoria Delpino; Astrid Zwerdling; Karina A Pasquevich; Clara García Samartino; Jorge C Wallach; Carlos A Fossati; Guillermo H Giambartolomei
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

3.  MicroRNA Expression Patterns of CD8+ T Cells in Acute and Chronic Brucellosis.

Authors:  Ferah Budak; S Haldun Bal; Gulcin Tezcan; Furkan Guvenc; E Halis Akalin; Guher Goral; Gunnur Deniz; H Barbaros Oral
Journal:  PLoS One       Date:  2016-11-08       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.